Jay Li
Impact in
-
- Cardiac Imaging and Diagnostics
- Radiation Dose and Imaging
-
- Liver Disease and Transplantation
Papers in
-
- Neurological disorders and treatments 5
- Parkinson's Disease Mechanisms and Treatments 2
- Oncology 3
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Jiang Hsieh (1 shared paper)Darin R. Okerlund (1 shared paper)Melissa Vass (1 shared paper)Xiangyang Tang (1 shared paper)Mónica Macal (2 shared papers)William T. Dauer (6 shared papers)Anne N. Fenton (2 shared papers)Thomas P. Prindiville (2 shared papers)
- Journals
- eLife (2 papers)Journal of Clinical Investigation (1 paper)JCI Insight (1 paper)ACS Chemical Neuroscience (1 paper)Movement Disorders (1 paper)
- Partner nations
- United StatesBrazilFrance
In The Last Decade
Jay Li
16 papers receiving 745 citations
Peers
Comparison fields: 5 of 87
- Radiology, Nuclear Medicine and Imaging 180
- Hepatology 46
- Oncology 103
- Neurology 62
- Virology 12
Countries citing papers authored by Jay Li
This map shows the geographic impact of Jay Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Li more than expected).
Fields of papers citing papers by Jay Li
This network shows the impact of papers produced by Jay Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Li. The network helps show where Jay Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 196 | |
| 2 | 2013 | 133 | |
| 3 | 2023 | 95 | |
| 4 | 2013 | 86 | |
| 5 | 2023 | 55 | |
| 6 | 2019 | 52 | |
| 7 | 2022 | 29 | |
| 8 | 2018 | 26 | |
| 9 | 2023 | 24 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 19 | |
| 12 | 2020 | 15 | |
| 13 | 2019 | 8 | |
| 14 | 2021 | 3 | |
| 15 | 2022 | 2 | |
| 16 | 2019 | 1 | |
| 17 | 2026 | 0 |
About Jay Li
Jay Li is a scholar working on Neurology, Oncology, Genetics, Radiology, Nuclear Medicine and Imaging and Clinical Biochemistry, having authored 17 papers that have together received 763 indexed citations. Recurring topics across this work include Neurological disorders and treatments (5 papers), Pancreatic and Hepatic Oncology Research (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Inflammatory Bowel Disease (2 papers), Acute Kidney Injury Research (1 paper), Effects and risks of endocrine disrupting chemicals (1 paper), Bacterial Identification and Susceptibility Testing (1 paper) and Sex and Gender in Healthcare (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (180 citations), Hepatology (46 citations), Oncology (103 citations), Neurology (62 citations) and Virology (12 citations). Jay Li has collaborated with scholars based in United States, Brazil and France. Frequent co-authors include Jiang Hsieh, Darin R. Okerlund, Melissa Vass, Xiangyang Tang, Mónica Macal, William T. Dauer, Anne N. Fenton, Thomas P. Prindiville, Irina Grishina and Sumathi Sankaran‐Walters. Their work appears in journals such as eLife, Journal of Clinical Investigation, JCI Insight, ACS Chemical Neuroscience and Movement Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.